ArticleOncotarget2015

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.

Kian Ngiap Chua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.